Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic prophylaxis before extracorporeal shock wave lithotripsy (APPEAL)
2016-001427-30Phase 4Completed
- Sponsor
- University of Helsinki
- Start
- Jun 2016
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ciprofloxacin in urinary tract infection (UTI), pyelonephritis and urosepsis, sponsored by University of Helsinki. Primary endpoint: Composite infectious outcome. Started Jun 2016; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
urinary tract infection (UTI)pyelonephritisurosepsis
Beyond the preview
Go deeper on 2016-001427-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001427-30.